stockrowAlvotech (ALVO) vs Pacira BioSciences, Inc. (PCRX)
- Alvotech ALVO 4.58 −1.93%
- Pacira BioSciences, Inc. PCRX 36.44 +0.11%
Alvotech and Pacira BioSciences, Inc. are both Drug Manufacturers Specialty & Generic companies. Alvotech is the larger, with a market value of $1.8B against $1.5B — 1.2× the size. Alvotech has negative trailing earnings, so its P/E is not meaningful; Pacira BioSciences, Inc. trades at 38.4×. Alvotech grew revenue faster over the last twelve months: 364.3% against 3.70%. Pacira BioSciences, Inc. has the higher net margin (5.08% vs −101.1%) and the higher return on invested capital (5.37% vs 0.00%). Across the 17 metrics below, Pacira BioSciences, Inc. leads on 12 and Alvotech on 5.
Valuation
Profitability
| Metric | ALVO | PCRX | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 42.71% | 0.00% | 53.51% |
| Operating margin | (42.43%) | 4.81% | 0.00% |
| Net margin | (101.05%) | 5.08% | (2.45%) |
| Free cash flow margin | 0.00% | 22.74% | 0.00% |
| Return on equity | 0.00% | 5.24% | (0.80%) |
| Return on assets | 0.00% | 3.02% | (1.67%) |
| Return on invested capital | 0.00% | 5.37% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack